Combined Nurr1 and Foxa2 roles in the therapy of Parkinson's diseaseopen access
- Authors
- Oh, Sang-Min; Chang, Mi-Yoon; Song, Jae-Jin; Rhee, Yong-Hee; Joe, Eun-Hye; Lee, Hyun-Seob; Yi, Sang-Hoon; Lee, Sang-Hun
- Issue Date
- May-2015
- Publisher
- WILEY
- Keywords
- Foxa2; gene therapy; midbrain dopamine neuron; Nurr1; Parkinson' s disease
- Citation
- EMBO MOLECULAR MEDICINE, v.7, no.5, pp.510 - 525
- Indexed
- SCIE
SCOPUS
- Journal Title
- EMBO MOLECULAR MEDICINE
- Volume
- 7
- Number
- 5
- Start Page
- 510
- End Page
- 525
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/157315
- DOI
- 10.15252/emmm.201404610
- ISSN
- 1757-4676
- Abstract
- Use of the physiological mechanisms promoting midbrain DA (mDA) neuron survival seems an appropriate option for developing treatments for Parkinson's disease (PD). mDA neurons are specifically marked by expression of the transcription factors Nurr1 and Foxa2. We show herein that Nurr1 and Foxa2 interact to protect mDA neurons against various toxic insults, but their expression is lost during aging and degenerative processes. In addition to their proposed cell-autonomous actions in mDA neurons, forced expression of these factors in neighboring glia synergistically protects degenerating mDA neurons in a paracrine mode. As a consequence of these bimodal actions, adeno-associated virus (AAV)-mediated gene delivery of Nurr1 and Foxa2 in a PD mouse model markedly protected mDA neurons and motor behaviors associated with nigrostriatal DA neurotransmission. The effects of the combined gene delivery were dramatic, highly reproducible, and sustained for at least 1year, suggesting that expression of these factors is a promising approach in PD therapy.
- Files in This Item
-
- Appears in
Collections - 서울 의과대학 > 서울 생화학·분자생물학교실 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/157315)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.